Johnson & Johnson has officially set up shop in Kendall Square.
Today is the day that Johnson & Johnson (NYSE: JNJ) cuts the ribbon on its Boston Innovation Center, the latest step in a broad initiative by the New Brunswick, NJ-based drug giant to help drive biotech innovation in certain life sciences hotspots around the globe—and strike deals to fatten up its pipeline.
Within the past three months, J&J has opened similar innovation centers in London and Menlo Park, CA, and plans to christen a fourth in Shanghai, China, as well.
To read the original article: J&J Cuts Ribbon on Boston Innovation Center, Touts Startup Deals | Xconomy
